Results 81 to 90 of about 4,216 (156)

[The course of acute hepatic porphyria].

Wiadomosci lekarskie (Warsaw, Poland : 1960), 1999
Acute hepatic porphyrias are the diseases dependent on the congenital metabolic defects of the hem biosynthesis. The diagnosis of porphyria only on the grounds of clinical picture is extremely difficult as it is presented by the variety of symptoms, often imitating other diseases.
W, Kucharski, E, Kostrzewska, W, Zawadzki   +2 more
openaire   +1 more source

Pharmacokinetic-pharmacodynamic model of urinary δ-aminolevulinic acid reduction after givosiran treatment in patients with acute hepatic porphyria. [PDF]

CPT Pharmacometrics Syst Pharmacol, 2023
Lee J, Melch M, Robbie GJ.
europepmc   +1 more source

EXPLORE B: A prospective, long-term natural history study of patients with acute hepatic porphyria with chronic symptoms. [PDF]

J Inherit Metab Dis, 2022
Cassiman D, Kauppinen R, Monroy S, Lee MJ, Bonkovsky HL, Thapar M, Guillén-Navarro E, Minder AE, Hale C, Sweetser MT, Ivanova A.   +10 more
europepmc   +1 more source

Disease burden in patients with acute hepatic porphyria: experience from the phase 3 ENVISION study. [PDF]

Orphanet J Rare Dis, 2022
Wang B, Ventura P, Takase KI, Thapar M, Cassiman D, Kubisch I, Liu S, Sweetser MT, Balwani M.   +8 more
europepmc   +1 more source

Adverse events of givosiran in the treatment of acute hepatic porphyria: a pharmacovigilance study using the FAERS and VigiAccess databases

Orphanet Journal of Rare Diseases
Background Acute hepatic porphyria is a rare metabolic disorder characterized by life-threatening acute attacks and chronic neurological symptoms. Givosiran is an RNA interference therapeutic approved by the FDA in 2019 to treat AHP by inhibiting hepatic
Yinpeng Xu, Fang Li, Li Huang, Mei Zhang, Pengqiang Du   +4 more
doaj   +1 more source

Pink urine as an inkling for a diagnostic dilemma: acute hepatic porphyria. [PDF]

BMJ Case Rep, 2021
Ibrahim S, Rao A, Shenoy RP.
europepmc   +1 more source

Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in Therapy. [PDF]

Drug Des Devel Ther, 2022
Majeed CN, Ma CD, Xiao T, Rudnick S, Bonkovsky HL.   +4 more
europepmc   +1 more source

Acute hepatic porphyria [PDF]

, 2020
openaire   +1 more source

Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals. [PDF]

J Intern Med, 2022
Lissing M, Vassiliou D, Floderus Y, Harper P, Bottai M, Kotopouli M, Hagström H, Sardh E, Wahlin S.   +8 more
europepmc   +1 more source

Hyponatremia and Abdominal Pain: A Case Report of Acute Hepatic Porphyria. [PDF]

Cureus
Roldão M, Soares Dionísio A, Duarte J, Salgadinho Machado A, Anastácio M.   +4 more
europepmc   +1 more source